Pharma Plus Medical Ltd - Accounts to registrar (filleted) - small 23.2.5

REGISTERED NUMBER: 07259684 (England and Wales)

Pharma Plus Medical Ltd

Unaudited Financial Statements

for the Year Ended 31st May 2023

Page

Company information

1

Balance sheet

2

to

3

Notes to the financial statements

4

to

6

Directors:

S N H Shah

H N Iqbal

Registered office:

4 Abbey Meadows

Morpeth

Northumberland

NE61 2BD

Registered number:

07259684 (England and Wales)

Accountants:

Rennie Welch LLP

Academy House

Shedden Park Road

Kelso

Roxburghshire

TD5 7AL

Fixed assets

Tangible assets

4

4,253

5,498

Current assets

Stocks

40,000

35,000

Debtors

5

138,080

89,581

Cash at bank

69,101

163,922

247,181

288,503

Creditors

Amounts falling due within one year

6

169,912

203,968

Net current assets

77,269

84,535

Total assets less current liabilities

81,522

90,033

Provisions for liabilities

-

1,045

Net assets

81,522

88,988

Capital and reserves

Called up share capital

1,000

1,000

Retained earnings

80,522

87,988

81,522

88,988

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st May 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st May 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of income and retained earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29th February 2024 and were signed on its behalf by:

S N H Shah - Director

1.	Statutory information

Pharma Plus Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	Accounting policies

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover arising from the sale of goods is recognised when the significant risks and rewards of ownership have passed to the buyer.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Motor vehicles

-

Straight line over 5 years

Tangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses.

Stocks

Stock is valued at the lower of cost and estimated selling price less costs to sell and after making due allowance for obsolete and slow moving items.

Financial instruments

The following assets and liabilities are classified as financial instruments - trade debtors, inter-company loans, trade creditors,accruals and directors' loans.

Directors' loans (being repayable on demand), inter-company loans, trade debtors, trade creditors and accruals are measured at the undiscounted amount of the cash or other consideration expected to be paid or received.

Financial assets that are measured at amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of Income and Retained Earnings.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Provisions

Provisions are set up only where it is probable that a present obligation exists as a result of an event prior to the balance sheet date and that a payment will be required in settlement that can be estimated reliably. Where material, provisions are calculated on a discounted basis.

Employee benefits

Short term employee benefits, including holiday pay, are recognised as an expense in the Statement of Income and Retained Earnings in the period in which they are incurred.

Going concern

The directors have considered the company's financial position for a minimum period of 12 months and beyond from the date of signing these financial statements and have an expectation that the company should be in a position to continue trading in the current format for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing these financial statements

3.	Employees and directors

The average number of employees during the year was 6 (2022 - 6 ) .

4.	Tangible fixed assets

Motor

vehicles

£

Cost

At 1st June 2022

and 31st May 2023

13,532

Depreciation

At 1st June 2022

8,034

Charge for year

1,245

At 31st May 2023

9,279

Net book value

At 31st May 2023

4,253

At 31st May 2022

5,498

5.

Debtors: amounts falling due within one year

2023

2022

£

£

Trade debtors

75,787

77,800

Amounts owed by group undertakings

22,055

3,912

Other debtors

40,238

7,869

138,080

89,581

6.

Creditors: amounts falling due within one year

2023

2022

£

£

Trade creditors

106,376

164,224

Amounts owed to group undertakings

-

21,857

Taxation and social security

19,503

15,254

Other creditors

44,033

2,633

169,912

203,968

7.	Other financial commitments

At 31st May 2023, the company had total commitments under non-cancellable operating leases over the remaining life of those leases of £143,000 (2022 - £156,000).

8.	Ultimate controlling party

Pharma Plus Medical Ltd is the wholy owned subsidiary of Health Hut Professionals Ltd a small company registered in England and Wales.